300039 Shanghai Kaibao Pharmaceutical
- 5.19
- -0.03-0.57%
Shanghai Kaibao Pharmaceutical News
Shanghai Kaibao Pharmaceutical: Announcement of Resolutions of the Fourth (Interim) Meeting of the Sixth Board of Directors
Shanghai Kaibao Pharmaceutical: 300039 Shanghai Kaibao Investor Relations Management Information 20240510
Shanghai Kaibao Pharmaceutical: Announcement on the renewal of the 2024 Audit Institution
Shanghai Kaibao Pharmaceutical: Independent Director Work System (April 2024)
Shanghai Kaibao Pharmaceutical: Report on the work of the Board of Supervisors for the year 2023
Shanghai Kaibao Pharmaceutical: 2023 Independent Director Debriefing Report (Jenny Lee)
Shanghai Kaibao Pharmaceutical: Internal Audit System (April 2024)
Shanghai Kaibao Pharmaceutical: Related Transaction Decision System (April 2024)
Shanghai Kaibao Pharmaceutical: 2023 Independent Director Debriefing Report (Tao Jiansheng)
Shanghai Kaibao Pharmaceutical: Articles of Association (April 2024)
Shanghai Kaibao Pharmaceutical: Announcement of Resolutions of the Second Meeting of the Sixth Board of Supervisors
Shanghai Kaibao Pharmaceutical: 2023 Independent Director Debriefing Report (Ye Zuguang)
Shanghai Kaibao Pharmaceutical: The Board's special opinion on the sole director's independence assessment
Shanghai Kaibao Pharmaceutical: Announcement on the forecast for daily related transactions in 2024
Shanghai Kaibao Pharmaceutical: Special Report on the Storage and Use of Funds Raised by Shanghai Kaibao in 2023
Shanghai Kaibao Pharmaceutical: 2023 Independent Director's Debriefing Report (Ma Hong)
Shanghai Kaibao Pharmaceutical: Dongwu Securities Co., Ltd.'s special inspection opinion on the storage and use of funds raised by Shanghai Kaibao Pharmaceutical Co., Ltd. in 2023
Shanghai Kaibao Pharmaceutical: Verification report on the annual storage and use of raised funds
Shanghai Kaibao Pharmaceutical: 2023 Annual Audit Report
Shanghai Kaibao Pharmaceutical: 2023 Social Responsibility Report
Analysis
Price Target
No Data
